Share
6,434 Posts.
lightbulb Created with Sketch. 5274
clock Created with Sketch. 22/10/18
16:10
Share
Originally posted by InX_
↑
Not quite.drug ' per se, but was able to patent the overall medication due to its new formulation.E vidence B ased M edicine (EBM ). We will always opt for whichever product has greater evidence backing its use and this often (but not always) means choosing older drugs on the market. Considering CannEpil is the second CBD formulation on the Australian market for human use, it ticks that box. Rest assured.
Expand
Thanks InX, for me a bit of a grey area with MC, but some great examples there & familiar with the Spiriva thing, it does become very technical & EBM definitely. Thank you for your post from an expert clinical pharmacological perspective.
(20min delay)